.jpg)
Introduction
In the constantly evolving landscape of pharmaceutical products, the Drug Enforcement Administration (DEA) has made significant updates to its list of excluded nonnarcotic products. This article sheds light on one such product, the nasal decongestant inhaler containing Levmetamfetamine, and the implications of these changes.
Levmetamfetamine: An Overview
Levmetamfetamine, a key component in nasal decongestants, is a nonnarcotic product now included in the DEA's updated exclusion list. It's mainly used to provide temporary relief from nasal congestion caused by colds, allergies, and sinusitis.
Manufacturers and Marketing
The nasal decongestant inhaler, containing 50 mg of Levmetamfetamine, is manufactured by Classic Pharmaceuticals, LLC. They market this product under various private labels, making it accessible to a wide range of consumers.
Federal Regulations and Exclusions
The nasal decongestant inhaler falls under the Federal Food, Drug, and Cosmetic Act. It may be sold over the counter without a prescription, excluding it from provisions of the Controlled Substances Act (CSA) pursuant to 21 U.S.C. 811(g)(1).
Implications of DEA's Final Rule
DEA's Final Rule not only updates the list of excluded nonnarcotic products but also impacts the regulation and marketing of these products. The inclusion of Levmetamfetamine-based nasal decongestants in this list has significant implications for both manufacturers and consumers.
Marketed Labels
Classic Pharmaceuticals markets the nasal decongestant inhaler under various private labels, including "Premier Value" and "Kroger" labels. This marketing strategy makes the product widely available to customers, enhancing its market reach.
Use and Benefits
Levmetamfetamine-based nasal decongestants are widely used for their immediate relief from nasal congestion symptoms. The benefits of these inhalers, along with their over-the-counter availability, make them a popular choice among consumers.
Over the Counter Availability
The nasal decongestant inhaler is lawfully sold over the counter, which means it can be purchased without a prescription. This availability makes it a convenient option for immediate relief from nasal congestion.
Conclusion
With the updated DEA rules, Levmetamfetamine-based nasal decongestants have been spotlighted, emphasizing their importance and widespread use. The over-the-counter availability and effectiveness of these inhalers make them a valuable product in the pharmaceutical market.
References
Drug Enforcement Administration (DEA). (2021). Final Rule. Retrieved from DEA website
Federal Food, Drug, and Cosmetic Act. (2021). Exclusion List. Retrieved from FDA website
Classic Pharmaceuticals, LLC. (2021). Product Information. Retrieved from Classic Pharmaceuticals website
Controlled Substances Act (CSA). (2021). Exclusion List. Retrieved from CSA website
Disclaimer: The information provided in this article is for educational purposes only. Always consult your healthcare provider before starting any medication or treatment.